Navigation Links
AlloSource Starts Construction on New Campus
Date:5/5/2011

CENTENNIAL, Colo., May 5, 2011 /PRNewswire/ -- AlloSource, a leading developer, processor, and distributor of bone and soft-tissue allografts for use in surgical procedures around the world, broke ground today on a new two-story building addition to their campus.  The construction project, designed by Intergroup Architects and built by The Weitz Company, also includes renovation of more than half of the existing facility.

"From design, to financing, to construction, the preparation for our new campus has been a labor of love for everyone involved since the expansion will further support AlloSource's mission to honor the gift of tissue donation and create new possibilities for patients in need," said Thomas Cycyota, AlloSource President and CEO.  "Additional space will allow us to maximize the impact of each donor. By consolidating our operations onto one campus and expanding our research lab and medical training facility, we will find new ways to better use donated tissue."

In the past year alone, AlloSource's workforce grew by more than 10 percent to support operation and administration development, and the Company expects its workforce to grow again by more than 10 percent in 2011.  

"AlloSource has been a prominent member of the Centennial business community since 2000, and we are proud that the company has decided to further expand its roots here," said Cathy Noon, Mayor of Centennial. "They are a strong contributor to the local economy and will continue to hire local professionals."

A nonprofit organization and one of the nation's premier tissue networks, AlloSource has provided a range of tissue allografts, including bone, skin and joint grafts throughout the country for more than 15 years. Over the last several years, AlloSource has outgrown its original Centennial headquarters and become separated in buildings around the business park.  A new centralized campus was the best solution to the company's growing needs.

"Upon learning more about what AlloSource does to honor the gift of donation and help patients in need with tissue transplants, it was easy to get passionate about the new building design," said Ned White, Intergroup Architects Principal.  "Great projects are the result of outstanding clients and AlloSource has truly been one."

The new building will include laboratory space, testing and research facilities, clean rooms, freezer storage and supply chain support, as well as office space, conference rooms, break rooms, equipment rooms and general storage.  The renovation work to the existing building will include freezer storage, receiving, material management, cleaning and sterilization space.  The Company also planned for future growth, leaving undeveloped space for further expansion.  

"As a tissue bank, AlloSource operates 24/7, so through intensive pre-planning and site coordination, we have ensured there will be no disruptions to operations throughout the project," said Orville Hinerman, Senior Vice President for The Weitz Company.  "We are honored to play a role in building AlloSource's legacy in Colorado and to further their valuable work in tissue donation and transplant."

Construction on AlloSource's new building is expected to be completed in spring 2012, while the existing building renovation is expected to be completed in fall 2012.

About AlloSource

AlloSource is a non-profit company that offers more than 200 precise bone, skin, soft-tissue and custom-machined allografts for use in an array of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has grown into one of the largest tissue networks in the country with more than 350 employees.  It is the world's largest processor of live cellular bone growth substitutes and delivers unparalleled expertise and customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations.   As one of the leading innovators in maximizing tissue donation with the goal of offering optimal solutions for healthcare providers and their patients, AlloSource is recognized by the medical community for its ability to process and provide high quality tissue.   The company is accredited by the American Association of Tissue Banks (AATB) and is headquartered in Centennial, CO. For more information, please visit allosource.org.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Thomas Cycyota
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=89921


'/>"/>
SOURCE AlloSource
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AlloSource, Tissue Recipient Join Stars of Life Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R)
2. AlloSource Distributes Record Amount of Tissue in 2008
3. AlloSource Named One of Colorados Top Three Healthcare Companies
4. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
5. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
6. The Pittsburgh Life Sciences Greenhouse Starts 2009 With Investment Momentum
7. BioCis Pharma Starts Phase IIa Trial in Psoriasis
8. Pierre Fabre Dermatologie Starts Clinical Trials on a Beta-Blocker to Treat Severe Infantile Haemangioma
9. AMT Starts Preregistration Trial for Glybera(TM)
10. KBI Biopharma Starts Cell Line Generation Process under Vendor Network Agreement for PER.C6(R)
11. EMA Starts Formal Review of Glybera(R) Dossier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:6/20/2016)... , June 20, 2016 Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... prisons involved, it has secured the final acceptance ... facilities for Managed Access Systems (MAS) installed. Furthermore, ... facilities to be installed by October, 2016. MAS ...
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
Breaking Biology News(10 mins):